Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Korro Bio (KRRO) Operating Income (2019 - 2025)

Korro Bio (KRRO) has disclosed Operating Income for 6 consecutive years, with -$19.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Operating Income rose 17.41% year-over-year to -$19.2 million, compared with a TTM value of -$94.5 million through Sep 2025, up 1.32%, and an annual FY2024 reading of -$91.9 million, down 8.73% over the prior year.
  • Operating Income was -$19.2 million for Q3 2025 at Korro Bio, up from -$27.2 million in the prior quarter.
  • Across five years, Operating Income topped out at $5.8 million in Q4 2022 and bottomed at -$27.2 million in Q2 2025.
  • Average Operating Income over 5 years is -$20.6 million, with a median of -$21.4 million recorded in 2021.
  • The sharpest move saw Operating Income soared 127.19% in 2022, then crashed 563.03% in 2023.
  • Year by year, Operating Income stood at -$21.4 million in 2021, then skyrocketed by 127.19% to $5.8 million in 2022, then plummeted by 563.03% to -$26.9 million in 2023, then grew by 14.33% to -$23.0 million in 2024, then grew by 16.51% to -$19.2 million in 2025.
  • Business Quant data shows Operating Income for KRRO at -$19.2 million in Q3 2025, -$27.2 million in Q2 2025, and -$25.0 million in Q1 2025.